Scaling Up Point-of-Care Hepatitis C Testing and Treatment in Canada
An Observational Study of Clinical Processes, Barriers, and Implementation Strategies
Led by McGill University · Updated on 2025-07-31
300
Participants Needed
12
Research Sites
65 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to understand how to expand point-of-care testing for hepatitis C virus HCV among key populations in Canada. It focuses on mapping current HCV care processes, identifying challenges and supports for implementing point-of-care testing, and collaborating with stakeholders to develop practical tools and strategies. The study is observational and seeks to provide evidence to guide the future adoption and sustainability of rapid HCV testing and treatment in various settings.
The study involves observing existing clinical care without directly implementing point-of-care HCV testing. It includes participants from different groups individuals at risk of HCV or attending related service sites, service providers and managers working at HCV service sites, policymakers involved in HCV testing and treatment planning, and laboratory or quality assurance professionals overseeing point-of-care testing. The research explores the feasibility, acceptability, and costs related to the use of rapid antibody and RNA tests for hepatitis C.
Participants will provide insights through surveys and interviews about current HCV care, barriers and facilitators to point-of-care testing, and strategies to improve testing delivery. The study will measure outcomes like barriers and facilitators based on implementation science frameworks, acceptability and feasibility of testing strategies, and sustainability through cost analysis over one year. The involvement period varies depending on participant roles, with data collected to inform future efforts to scale up hepatitis C testing and treatment nationally.
CONDITIONS
Brief Title
Scaling Up Point-of-Care Hepatitis C Testing and Treatment in Canada
Research Team
M
Meagan Mooney, RN, MA, BSc
C
Charlene Weight, MSc, BSc
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Individuals aged 18 years or older who have a risk factor for hepatitis C acquisition or are attending a site that provides services to people with hepatitis C risk.
Service providers and managers currently employed at a site providing hepatitis C-related services, involved in or supervising delivery of those services.
Policymakers holding positions in local, provincial, or national government or health authorities influencing hepatitis C testing and treatment policies and able to provide insights into planning and funding.
Laboratory and quality assurance stakeholders with roles in laboratory services, quality assurance, or regulatory oversight of point-of-care testing at provincial, national, or organizational levels.
You will not qualify if you...
Individuals younger than 18 years old.
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Diagnostic Evaluation
Duration - Single visit
Participants undergo point-of-care hepatitis C antibody and RNA testing to diagnose current or past infection.
1 visit (in-person)
Long-term Monitoring
Duration - Up to 1 year
Participants are observed over time to identify barriers and facilitators to point-of-care hepatitis C testing and treatment, and to assess the acceptability, feasibility, and sustainability of testing strategies.
Periodic visits depending on participant role and cohort
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Similar Trials
Pilot Study of a Peer-Driven Injection Setting Intervention to Prevent HIV, Hepatitis C, and Overdose Among People Who Inject Drugs in Baltimore
Study of Changes in Bile Acid Profile and Gut Microbiota in Adults Treated with Bulevirtide for Hepatitis Delta Virus Infection
Evaluation of MagIA Multiplex Test for HIV, Hepatitis B, Hepatitis C, and Syphilis Detection in Sub-Saharan Africa
Study of a Nutritional Supplement With Resveratrol, Quercetin, Taurine, Inulin, and Whey Protein to Improve Liver Health in Adults With Chronic Hepatitis C
Evaluating an Electronic Medical Record Alert for Triple Screening of HIV, Hepatitis B, and Hepatitis C in Primary Care Encounters
Study to Identify and Link People With Untreated or Unknown Hepatitis B, Hepatitis D, and Hepatitis C Infections in South-East Austria
Timing of Direct-Acting Antiviral Treatment in Kidney Transplant Recipients of Hepatitis C Virus-Positive Donor Kidneys A Randomized Controlled Trial
Scaling Up Point-of-Care Hepatitis C Testing and Treatment in Canada
An Observational Study of Clinical Processes, Barriers, and Implementation Strategies
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Scaling up point-of-care hepatitis C testing in Canada: protocol for a multilevel implementation science study of clinical processes, barriers, facilitators and implementation strategies (SCALE-POCT study).